New AI-driven technologies demonstrate significant strides in molecular biology. Microsoft's BioEmu generative deep learning model rapidly predicts protein dynamics, enabling large-scale structural ensemble simulations. Scripps Research developed a microchip for accelerated antibody-virus interaction mapping from small blood samples, enhancing vaccine research. Additionally, Circular Genomics advances circRNA biomarker studies for Alzheimer’s diagnosis with Alzheimer's Drug Discovery Foundation support.